Kyorin Pharmaceutical Co., Ltd.
Records under this name other than the patents Kyorin Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Kyorin Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,318,811 | Method for treating an inflammatory bowel disease using 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol or a salt thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,457,012 | Transdermal absorption preparation Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,224,604 | Treatment of Graft Versus Host Disease in Transplant Patients Formerly held In force · High confidence | In force | High confidence | |
| US 11,376,253 | An Agent for Treating Nocturnal Pollakiuria Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 11,326,163 | Therapeutic Agent for Fibrosis Lapsed on the fee record Ended May 10, 2026 · High confidence | Lapsed on the fee record | Ended May 10, 2026 | High confidence |
| US 7,781,617 | Effective use method of medicaments and method of preventing expression of side effect Formerly held Term ended Term ended Mar 13, 2026 · USPTO record | Term ended | Term ended Mar 13, 2026 | USPTO record |
| US 9,863,955 | AMPK activator screening method, and AMPK activator Lapsed on the fee record Ended Jan 9, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 9, 2026 | USPTO record |
| US 8,569,270 | Diphenyl sulfide derivatives and medicines containing same as active ingredient Lapsed on the fee record Ended Oct 29, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 29, 2025 | USPTO record |
| US 8,501,965 | Method for producing 3-substituted-4-fluoropyrrolidine derivative Lapsed on the fee record Ended Aug 6, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2025 | USPTO record |
| US 7,807,854 | Effective use method of medicaments and method of preventing expression of side effect Formerly held Term ended Term ended Jul 15, 2025 · USPTO record | Term ended | Term ended Jul 15, 2025 | USPTO record |